Altimmune (ALT) Short Interest Ratio & Short Volume → The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad) Free ALT Stock Alerts $7.72 +0.56 (+7.82%) (As of 05/9/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Altimmune Short Interest DataCurrent Short Volume20,370,000 sharesPrevious Short Volume17,730,000 sharesChange Vs. Previous Month+14.89%Dollar Volume Sold Short$153.79 millionShort Interest Ratio / Days to Cover4.3Last Record DateApril 15, 2024Outstanding Shares70,890,000 sharesPercentage of Shares Shorted28.73%Today's Trading Volume4,338,899 sharesAverage Trading Volume5,109,830 sharesToday's Volume Vs. Average85% Short Selling Altimmune ? Sign up to receive the latest short interest report for Altimmune and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatALT Short Interest Over TimeALT Days to Cover Over TimeALT Percentage of Float Shorted Over Time Ad InvestorPlace1970’s computer coder Issues Shocking AI WarningLouis Navellier has spent four decades building a billion-dollar empire on the back of big data and technology… Now he's stepping forward with a shocking warning about how AI will soon impact the wealth of everyday Americans.Click here to watch his new video ASAP Altimmune Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202420,370,000 shares $153.79 million +14.9%N/A4.3 $7.55 3/31/202417,730,000 shares $180.49 million +41.7%N/A3.2 $10.18 3/15/202412,510,000 shares $123.35 million +15.7%N/A1.9 $9.86 2/29/202410,810,000 shares $130.80 million -6.4%N/A1.1 $12.10 2/15/202411,550,000 shares $103.37 million +15.4%N/A1 $8.95 1/31/202410,010,000 shares $94.49 million -6.1%N/A0.9 $9.44 Get the Latest News and Ratings for ALT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Altimmune and its competitors with MarketBeat's FREE daily newsletter. 1/15/202410,660,000 shares $127.92 million +12.9%N/A1 $12.00 12/31/20239,440,000 shares $106.20 million -14.9%N/A1 $11.25 12/15/202311,090,000 shares $85.06 million +71.9%N/A1.3 $7.67 11/30/20236,450,000 shares $20.38 million -4.2%N/A1 $3.16 11/15/20236,730,000 shares $16.42 million -1.9%N/A5.8 $2.44 10/31/20236,860,000 shares $16.53 million -7.3%N/A5.9 $2.41 10/15/20237,400,000 shares $19.68 million +3.5%N/A6.9 $2.66 9/30/20237,150,000 shares $18.59 million +9.3%N/A6.5 $2.60 9/15/20236,540,000 shares $19.10 million +8.5%N/A5.3 $2.92 8/31/20236,030,000 shares $15.26 million +4.3%N/A3.7 $2.53 8/15/20235,780,000 shares $16.24 million -6.2%N/A3.3 $2.81 7/31/20236,160,000 shares $20.39 million -16.2%N/A3.4 $3.31 7/15/20237,350,000 shares $24.11 million +5.6%N/A4.1 $3.28 6/30/20236,960,000 shares $24.57 million -23.8%N/A3.6 $3.53 6/15/20239,130,000 shares $37.34 million +0.6%N/A4.3 $4.09 5/31/20239,080,000 shares $36.68 million +2.6%N/A4.2 $4.04 5/15/20238,850,000 shares $42.92 million -2.1%N/A4.3 $4.85 4/30/20239,040,000 shares $45.65 million -8.3%N/A4.5 $5.05 4/15/20239,860,000 shares $47.13 million +3.8%N/A4.8 $4.78 3/31/20239,500,000 shares $40.09 million +28.4%N/A4.9 $4.22 3/15/20237,400,000 shares $80.88 million +16.0%N/A3.9 $10.93 2/28/20236,380,000 shares $80.32 million +1.9%N/A4.6 $12.59 2/15/20236,260,000 shares $75.06 million +1.5%N/A4.5 $11.99 1/31/20236,170,000 shares $84.16 million -15.7%N/A4.3 $13.64 1/15/20237,320,000 shares $119.24 million -3.4%N/A5.3 $16.29 12/30/20227,580,000 shares $124.69 million +19.6%N/A5.6 $16.45 12/15/20226,340,000 shares $66.38 million -3.4%N/A4.5 $10.47 11/30/20226,560,000 shares $65.27 million -10.0%N/A2.9 $9.95 11/15/20227,290,000 shares $79.61 million +1.8%N/A3.2 $10.92 10/31/20227,160,000 shares $89.79 million +1.6%N/A2.9 $12.54 10/15/20227,050,000 shares $73.32 million -8.4%N/A2.9 $10.40 9/30/20227,700,000 shares $98.33 million +13.9%N/A3.1 $12.77 9/15/20226,760,000 shares $97.28 million +9.7%N/A2.6 $14.39 8/31/20226,160,000 shares $136.01 million +26.8%N/A3.3 $22.08The #1 Crypto for AI (Ad)We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”Learn more about it by watching THIS NOW. ALT Short Interest - Frequently Asked Questions What is Altimmune's current short interest? Short interest is the volume of Altimmune shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 20,370,000 shares of ALT short. Learn More on Altimmune's current short interest. What is a good short interest ratio for Altimmune? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ALT shares currently have a short interest ratio of 4.0. Learn More on Altimmune's short interest ratio. Which institutional investors are shorting Altimmune? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Altimmune: Concourse Financial Group Securities Inc., Simplex Trading LLC, IMC Chicago LLC, and IMC Chicago LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Altimmune's short interest increasing or decreasing? Altimmune saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 20,370,000 shares, an increase of 14.9% from the previous total of 17,730,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Altimmune's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Altimmune: KalVista Pharmaceuticals, Inc. (13.80%), Verve Therapeutics, Inc. (28.64%), Travere Therapeutics, Inc. (15.50%), Larimar Therapeutics, Inc. (5.69%), Oculis Holding AG (0.13%), Shattuck Labs, Inc. (4.42%), COMPASS Pathways plc (5.39%), Adlai Nortye Ltd. (0.02%), Arbutus Biopharma Co. (2.74%), Astria Therapeutics, Inc. (11.33%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Altimmune stock? Short selling ALT is an investing strategy that aims to generate trading profit from Altimmune as its price is falling. ALT shares are trading down $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Altimmune? A short squeeze for Altimmune occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ALT, which in turn drives the price of the stock up even further. How often is Altimmune's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALT, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: KALV Short Squeeze VERV Short Squeeze TVTX Short Squeeze LRMR Short Squeeze OCS Short Squeeze STTK Short Squeeze CMPS Short Squeeze ANL Short Squeeze ABUS Short Squeeze ATXS Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ALT) was last updated on 5/9/2024 by MarketBeat.com Staff From Our Partners1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 Media348 million Americans lives to END as we know it?The Oxford ClubThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersObama’s Forever Term [exposed]Porter & Company